Includes: New characteristics of aggressive prostate cancer identified, how to treat recurring prostate cancer, apalutamide vs. darolutamide in mCSPC,

Includes: Spotlighting the Top 10 FDA Oncology Approvals in 2025, CaverSTIM device shows initial promise for post-prostatectomy erectile dysfunction,

Includes: Prostate cancer cells thrive in bone tissue, Top 10 Urology Times prostate cancer articles of 2025, Reversing treatment resistance in prostate cancer,

Includes: Focused ultrasound offers safe and effective prostate cancer treatment, Neuromodulation therapy for erectile dysfunction after radical prostatectomy,

Includes: Drug combo cuts risk of death in advanced prostate cancer by 40%, targeting enzymes to weaken cancer cells could supercharge treatment,

Includes: Tailgating With Dr. Digital 2025, Prostate Cancer Stage Increasing, Survival Gains Slowing in the United States, protecting against erectile dysfunction,

Includes: Mindfulness for Managing Cancer-Related Stress, Cancer drug eliminates aggressive cancers in Phase I trial, Novel alpha particle therapy holds promise,

Includes: scientists uncover immune cells that help prostate cancer resist treatment, Enzalutamide prolongs survival, why some men experience incontinence,

Includes: biomarkers hold clue in treating aggressive prostate cancer, exercise may help, acupuncture may alleviate nocturia,